Serina Therapeutics SER
NYSE SER
$1.78 +0.01 (+0.56%)
As of: Oct 22, 2026 · 2:35 PM EDT

Serina Therapeutics (SER) Other Operating Expenses (2018 - 2019)

Updated

Serina Therapeutics (SER) reported Other Operating Expenses of -$6.89 million for Q1 2019.

Analysis

Serina Therapeutics (SER) Other Operating Expenses (2018 - 2019) Analysis & Trends

For FY2018, Serina Therapeutics posted Other Operating Expenses of -$23.75 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Serina Therapeutics 29.17 Mn -11.58 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 -6.89 Mn
Dec 31, 2018 -6.98 Mn
Sep 30, 2018 -5.17 Mn
API Access

Serina Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=SER&period=max&api_key=YOUR_API_KEY